None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male or female, 18 45 years old 2. Visible dark spots or pigmentation 3. Willing to provide written informed consent 4. Women of childbearing potential must have a negative urine pregnancy test 5. Able and willing to comply with study procedures
Exclusion criteria
Exclusion criteria: 1.Pregnant or breastfeeding women 2.History of systemic or skin cancers within the last 5 years 3.Open sores or lesions in the treatment area 4.Participation in another interventional trial within the past 90 days 5.Known hypersensitivity to serum ingredients 6.Use of immunosuppressive or immunomodulatory medications 7.Any dermatological or systemic condition that may interfere with study results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Change in Skin dark spots 2. Change in Skin gloss 3. Change in Skin lightness 4. Change in Skin Pigmentation 5. Change in Dermatological Evaluation 6. DSLR ImagingTimepoint: At Day 0, Day 7, Day 14, Day 21 & Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in Hydration 2. Change in TEWLTimepoint: At Day 0, 30 min, Day 7, Day 14, Day 21 & Day 28;1.Change in Skin SebumTimepoint: At (Day0 (0min, 6hrs), Day 7, Day 14, Day 21, Day 28 | — |
Countries
India
Contacts
CCFT Laboratories